KCAS-Blog_Thumbnail-Banner_Xtalks-Discovery-Webinar Blogs
Read article Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification (Pre-Recorded Webinar)

How confident are you in your CRO’s support of your drug discovery program? Maybe you should take a closer look… Support of drug discovery programs is essential in providing integrated drug development services.  The key is having the expertise to also be able tackle not only complex matrices but any…

PATTERN_ORANGE_1320x780_2 Blogs
Read article Bioanalytical Strategy Across the Drug Development Paradigm

At KCAS, we work with Director, VP, and C-level pharmaceutical and biotech executives that need to measure their drug or the effect of their drug in biological matrix. Many of our customers rely on…

PATTERN_BLUE_1320x780_2 Blogs
Read article Q and A: Immunoaffinity and Hybrid LC-MS/MS

Biomarker are key drivers in the drug development process.  Frequently, developing a panel of biomarkers to test a particular mechanism or hypothesis is critical to the success of a drug.  At KCAS, we develop assays for custom panels or individual biomarkers based on client needs and can also assist with…

PATTERN_BLUE_1320x780 Blogs
Read article Evolving to Meet Demand in a Changing Industry

The paradigm of drug development outsourcing is in a period of rapid transition coupled with a growing market in a competitive space. Today’s service providers are hardly recognizable from a decade ago and if the continued evolution in the market is any indicator, it is safe to say the next…

PATTERN_AMBER_1320x780 Blogs
Read article Solving Discovery Bottlenecks at KCAS

Everyone likes to claim they offer fast turnaround times, but clients often come to KCAS having been burned by the lack of timeliness on their Discovery projects. At KCAS, we incorporate our clients’ priorities at the top of our priorities. We have put together a Discovery team with decades of…

Thumb_July_Pharma_Changes-AnimalHealth Blogs
Read article Changes in Animal Health Product Support at KCAS

Animal health programs have consistently been supported by KCAS with increasing study complexities although they have constituted a small percentage of the overall pharmaceutical development, these programs have consistently been supported by KCAS with increasing study complexities. ANIMAL HEALTH – LABORATORY SUPPORT KCAS is not only centrally located in…

Thumb_July_Pharma_Changes-Biopharma Blogs
Read article Changes in LBA Biopharma at KCAS

The bioanalytical landscape for support of biopharmaceuticals (biologics or large molecules) and biomarker testing is an ever changing map. The industry is currently focused on low level sensitivity, data integrity, and compliance with the…

PATTERN_AMBER_1320x780_3 Blogs
Read article Protein Characterization at KCAS

Protein characterization is a broad term describing the profile or fingerprint of a large molecule’s (or biologic’s) physical, chemical, and biological properties. Characterization of the protein will test the purity, activity, and the quantity…

PATTERN_ORANGE_1320x780_3 Blogs
Read article Global Clinical Sample Logistics at KCAS

If you’re running a clinical or preclinical study, there are many components that you need to think about, plan, and execute. One is “what the heck do I do with these samples we’re collecting”…

PATTERN_AMBER_1320x780 Blogs
Read article Old vs. New Technologies at KCAS

Adoption of technology has a life cycle that typically follows a bell-shaped curve. There are early adopters, early majority, late majority, and laggards. Adopting technology early comes with a risk, as not all technologies are widely adopted and many are very short lived. Adopting late also comes with a risk,…

PATTERN_BLUE_1320x780_3 Blogs
Read article Cell-Based Biomarker & PD Support at KCAS

As the Bioanalytical support for drug development continues to grow, more and more scientists are requiring more complex assays. Two examples are cell based assays and what we refer to as live cell assays.

PATTERN_ORANGE_1320x780 Blogs
Read article Navigating the FDA’s Tobacco Regulations

The FDA has regulated cigarettes, smokeless and loose tobacco since 2009 under the Tobacco Control Act. In 2016, the FDA finalized a rule for the regulation of all tobacco products, making it illegal to sell e-cigarettes, cigars and hookah tobacco to anyone under 18 and requiring retailers to check photo…